Prof Jon Watson




Filter by


Leasing a medical curriculum: what's it worth?

David Prideaux, Julie Ash, Simon Broadley, Brendan Crotty, William Hart, Judy Searle, Jon Watson, Lindon Wing, Paul Worley

(2019), Vol. 41, pp. 697-702, Medical teacher, London, Eng., C1


Neocarzinostatin, aptamer conjugates for targeting EpCAM-positive tumor cells

P Athyala, J Kanwar, S Chitipothu, R Kanwar, S Krishnakumar, J Watson, J Narayanan

(2017), Vol. 37, pp. 3615-3629, Anticancer research, Kapandriti Attica, Greece, C1


Cohort analysis of simulation-based medical training for decision support

J Zhang, S Hanoun, B Khan, D Creighton, S Nahavandi, K Britt, K D'Souza, J Watson, R Yanieri

(2017), pp. 2608-2612, SMC 2017 : Proceedings of the IEEE International Conference on Systems, Man, and Cybernetics, Banff, Canada, E1


Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer

P Athyala, J Kanwar, M Alameen, R Kanwar, S Krishnakumar, J Watson, U Vetrivel, J Narayanan

(2016), Vol. 469, pp. 257-262, Biochemical and biophysical research communications, Amsterdam, The Netherlands, C1


Nurse-led clinic: effective and efficient delivery of assessment and review of patients with hepatitis B and C

M Biddle, N Adler, S Heath, S Streat, M Wardrop, J Watson

(2014), Vol. 44, pp. 581-585, Internal Medicine Journal, Richmond, Vic., C1


Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?

N Friedman, J Green, H Weber, S Stephen, S Lane, A Ting, J Watson

(2014), Vol. 4, pp. 214-220, Journal of clinical and experimental hepatology, Gurgaon, India, C1


Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies

Stuart Roberts, Joanne Mitchell, Reynold Leung, David Booth, Steven Bollipo, George Ostapowicz, Andrew Sloss, Geoffrey McCaughan, Gregory Dore, Alexander Thompson, Darrell Crawford, William Sievert, Martin Weltman, Wendy Cheng, Jacob George, Australian Liver Association Clinical Research Net, Johnathan Watson

(2014), Vol. 29, pp. 179-184, Journal of gastroenterology and hepatology, Chichester, Eng., C1


Chronic hepatitis C

J Watson, C Hair

(2008), Vol. 9, pp. 66-67, Medicine Today, C1-1


The tissue effect of argon plasma coagulation on esophageal and gastric mucosa

J Watson, M Bennett, S Griffin, K Matthewson

(2000), Vol. 52, pp. 342-345, Gastrointestinal endoscopy, Amsterdam, The Netherlands, C1-1


Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study

J Watson, D Jones, O James, P Cann, M Bramble

(1999), Vol. 14, pp. 1034-1040, Journal of gastroenterology and hepatology, Chichester, Eng., C1-1


Massively elevated serum ferritin in an ill man with abnormal liver function tests

J Watson, M Bramble, S Ghosh

(1998), Vol. 74, pp. 619-620, Postgraduate medical journal, London, Eng., C1-1


Percutaneous endoscopic gastroenterostomy and jejunal extension for gastric stasis in pancreatic carcinoma

J Watson, K Mannix, K Matthewson

(1997), Vol. 11, pp. 407-410, Palliative medicine, London, Eng., C1-1


Hepatitis C virus: Epidemiology and genotypes in the north east of England

J Watson, A Brind, C Chapman, C Bates, F Gould, S Johnson, A Burt, J Ferguson, P Simmonds, M Bassendine

(1996), Vol. 38, pp. 269-276, Gut, C1-1


Hepatitis C virus infection in the elderly

A Brind, J Watson, O James, M Bassendine

(1996), Vol. 89, pp. 291-296, QJM: an international journal of medicine, Oxford, Eng., C1-1


Non-Hodgkin's lymphoma and hepatitis C virus infection

A Brind, J Watson, A Burt, P Kestevan, J Wallis, S Proctor, M Bassendine

(1996), Vol. 21, pp. 127-130, Leukemia and lymphoma, Abingdon, Eng., C1-1


Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients

J Watson, D Bevitt, G Spickett, G Toms, M Bassendine

(1996), Vol. 25, pp. 599-607, Journal of hepatology, Amsterdam, The Netherlands, C1-1


Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

G Dusheiko, J Main, H Thomas, O Reichard, C Lee, A Dhillon, S Rassam, A Fryden, H Reesink, M Bassendine, G Norkrans, T Cuypers, N Lelie, P Telfer, J Watson, C Weegink, P Sillikens, O Weiland

(1996), Vol. 25, pp. 591-598, Journal of hepatology, Amsterdam, The Netherlands, C1-1


Prokaryotic expression and analysis of the antibody response to a Newcastle isolate of the core gene of hepatitis C

I Milton, M Carter, G Toms, J Watson, M Bassendine, K Quo

(1995), Vol. 45, pp. 253-258, Journal of medical virology, Chichester, Eng., C1-1


Funded Projects at Deakin

Industry and Other Funding

Support Funding Appointment for to Head of Research at OrthoSport Victoria Research Unit.

Prof Jon Watson

  • 2019: $144,499
  • 2018: $155,000
  • 2017: $150,000
  • 2016: $100,000
  • 2015: $100,000
  • 2014: $100,000
  • 2013: $50,000


Associate Supervisor

Prasanna Kumar Athyala

Thesis entitled: Oligonucleotide-Conjugates for Targeting EpCAM Positive Tumor Cells

Doctor of Philosophy (Medicine), School of Medicine